Coexistence of mupirocin and antiseptic resistance in methicillin-resistant Staphylococcus aureus isolates from Korea

Diagnostic Microbiology and Infectious Disease

Volumn 75, Issue 3, 2013, Pages 308-312

  Lee, Hyukmin ^a   Lim, Hwansub ^a   Bae, Il Kown ^b   Yong, Dongeun ^b   Jeong, Seok Hoon ^b   Lee, Kyungwon ^b   Chong, Yunsop ^b  

^a Kwandong University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Antiseptics; MRSA; Mupirocin; Resistance

Indexed keywords

ANTIINFECTIVE AGENT; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; OXACILLIN; PENICILLIN G; PSEUDOMONIC ACID; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CONTROLLED STUDY; GENE SEQUENCE; ILES GENE; KOREA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTILOCUS SEQUENCE TYPING; MUPA GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QACA GENE; QACB GENE; SECONDARY HEALTH CARE; SMR GENE; TERTIARY HEALTH CARE;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; ANTIPORTERS; BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENES, BACTERIAL; HUMANS; INCIDENCE; MEMBRANE TRANSPORT PROTEINS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; MUPIROCIN; NUCLEAR PROTEINS; REPUBLIC OF KOREA; STAPHYLOCOCCAL INFECTIONS; TERTIARY CARE CENTERS;

EID: 84873723868     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2012.11.025     Document Type: Article

References (34)

1. Ammerlaan H.S., Kluytmans J.A., Wertheim H.F., Nouwen J.L., Bonten M.J. Eradication of methicillin-resistant Staphylococcus aureus carriage: a systematic review. Clin Infect Dis 2009, 48:922-930.
2. Antonio M., McFerran N., Pallen M.J. Mutations affecting the Rossman fold of isoleucyl-tRNA synthetase are correlated with low-level mupirocin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 2002, 46:438-442.
3. Batra R., Cooper B.S., Whiteley C., Patel A.K., Wyncoll D., Edgeworth J.D. Efficacy and limitation of a chlorhexidine-based decolonization strategy in preventing transmission of methicillin-resistant Staphylococcus aureus in an intensive care unit. Clin Infect Dis 2010, 50:210-217.
4. Boucher H.W., Corey G.R. Epidemiology of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2008, 46(Suppl 5):S344-S349.
5. Calfee D.P. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci, and other Gram-positives in healthcare. Curr Opin Infect Dis 2012, 25:385.
6. Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing; nineteenth informational supplement 2009, CLSI, Wayne, PA.
7. Eltringham I. Mupirocin resistance and methicillin-resistant Staphylococcus aureus (MRSA). J Hosp Infect 1997, 35:1-8.
8. Enright M.C., Day N.P., Davies C.E., Peacock S.J., Spratt B.G. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 2000, 38:1008-1015.
9. Harmsen D., Claus H., Witte W., Rothgänger J., Claus H., Turnwald D., et al. Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol 2003, 41:5442-5448.
10. Hodgson J.E., Curnock S.P., Dyke K.G., Morris R., Sylvester D.R., Gross M.S. Molecular characterization of the gene encoding high-level mupirocin resistance in Staphylococcus aureus J2870. Antimicrob Agents Chemother 1994, 38:1205-1208.
11. Köck R., Becker K., Cookson B., van Gemert-Pijnen J.E., Harbarth S., Kluytmans J., et al. Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Euro Surveill 2010, 15:19688.
12. Lee K., Chang C.L., Lee N.Y., Kim H.S., Hong K.S., Cho H.C. Korean Nationwide Surveillance of Antimicrobial Resistance of Bacteria in 1998. Yonsei Med J 2000, 41:497-506.
13. Lee H., Kim C.K., Lee J., Lee S.H., Ahn J.Y., Hong S.G., et al. Antimicrobial resistance of clinically important bacteria isolated from 12 hospitals in Korea in 2005 and 2006. Korean J Clin Microbiol 2007, 10:59-69.
14. Lee A.S., Macedo-Vinas M., François P., Renzi G., Schrenzel J., Vernaz N., et al. Impact of combined low-level mupirocin and genotypic chlorhexidine resistance on persistent methicillin-resistant Staphylococcus aureus carriage after decolonization therapy: a case-control study. Clin Infect Dis 2011, 52:1422-1430.
15. Lee K., Kim M.N., Kim J.S., Hong H.L., Kang J.O., Shin J.H., et al. Further increases in carbapenem-, amikacin-, and fluoroquinolone-resistant isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR study 2009. Yonsei Med J 2011, 52:793-802.
16. Littlejohn T.G., DiBerardino D., Messerotti L.J., Spiers S.J., Skurray R.A. Structure and evolution of a family of genes encoding antiseptic and disinfectant resistance in Staphylococcus aureus. Gene 1991, 101:59-66.
17. Mayer S., Boos M., Beyer A., Fluit A.C., Schmitz F.J. Distribution of the antiseptic resistance genes qacA, qacB and qacC in 497 methicillin-resistant and -susceptible European isolates of Staphylococcus aureus. J Antimicrob Chemother 2001, 47:896-897.
18. Miyazaki N.H., Abreu A.O., Marin V.A., Rezende C.A., Moraes M.T., Villas BÔas M.H. The presence of qacA/B gene in Brazilian methicillin-resistant Staphylococcus aureus. Mem Inst Oswaldo Cruz 2007, 102:539-540.
19. Moellering R.C. MRSA: The first half century. J Antimicrob Chemother 2012, 67:4-11.
20. Noguchi N., Hase M., Kitta M., Sasatsu M., Deguchi K., Kono M. Antiseptic susceptibility and distribution of antiseptic-resistance genes in methicillin-resistant Staphylococcus aureus. FEMS Microbiol Lett 1999, 172:247-253.
21. Noguchi N., Suwa J., Narui K., Sasatsu M., Ito T., Hiramatsu K., et al. Susceptibilities to antiseptic agents and distribution of antiseptic-resistance genes qacA/B and smr of methicillin-resistant Staphylococcus aureus isolated in Asia during 1998 and 1999. J Med Microbiol 2005, 54:557-565.
22. Noskin G.A., Rubin R.J., Schentag J.J., Kluytmans J., Hedblom E.C., Smulders M., et al. The burden of Staphylococcus aureus infections on hospitals in the United States: an analysis of the 2000 and 2001 Nationwide Inpatient Sample Database. Arch Intern Med 2005, 165:1756-1761.
23. Patel J.B., Gorwitz R.J., Jernigan J.A. Mupirocin resistance. Clin Infect Dis 2009, 49:935-941.
24. Paulsen I.T., Brown M.H., Littlejohn T.G., Mitchell B.A., Skurray R.A. Multidrug resistance proteins QacA and QacB from Staphylococcus aureus: membrane topology and identification of residues involved in substrate specificity. Proc Natl Acad Sci U S A 1996, 93:3630-3635.
25. Rahman M., Noble W.C., Cookson B., Baird D., Coia J. Mupirocin resistant Staphylococcus aureus. Lancet 1987, 330:387-388.
26. Sheng W.H., Wang J.T., Lauderdale T.L., Weng C.M., Chen D., Chang S.C. Epidemiology and susceptibilities of methicillin-resistant Staphylococcus aureus in Taiwan: emphasis on chlorhexidine susceptibility. Diagn Microbiol Infect Dis 2009, 63:309-313.
27. Simor A.E., Phillips E., McGeer A., Konvalinka A., Loeb M., Devlin H.R., et al. Randomized controlled trial of chlorhexidinegluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. Clin Infect Dis 2007, 44:178-185.
28. Smith K., Gemmell C.G., Hunter I.S. The association between biocide tolerance and the presence or absence of qac genes among hospital-acquired and community-acquired MRSA isolates. J Antimicrob Chemother 2008, 61:78-84.
29. Tennent J.M., Lyon B.R., Midgley M., Jones I.G., Purewal A.S., Skurray R.A. Physical and biochemical characterization of the qacA gene encoding antiseptic and disinfectant resistance in Staphylococcus aureus. J Gen Microbiol 1989, 135:1-10.
30. vanRijen M.M., Bonten M., Wenzel R.P., Kluytmans J.A. Intranasal mupirocin for reduction of Staphylococcus aureus infections in surgical patients with nasal carriage: a systematic review. J Antimicrob Chemother 2008, 61:254-261.
31. Walsh S.E., Maillard J.Y., Russell A.D., Catrenich C.E., Charbonneau D.L., Bartolo R.G. Development of bacterial resistance to several biocides and effects on antibiotic susceptibility. J Hosp Infect 2003, 55:98-107.
32. Wertheim H.F., Melles D.C., Vos M.C., van Leeuwen W., van Belkum A., Verbrugh H.A., et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 2005, 5:751-762.
33. Yang J.A., Park D.W., Sohn J.W., Yang I.S., Kim K.H., Kim M.J. Molecular analysis of isoleucyl-tRNA synthetase mutations in clinical isolates of methicillin-resistant Staphylococcus aureus with low-level mupirocin resistance. J Korean Med Sci 2006, 21:827-832.
34. Yun H.J., Lee S.W., Yoon G.M., Kim S.Y., Choi S., Lee Y.S., et al. Prevalence and mechanisms of low- and high-level mupirocin resistance in staphylococci isolated from a Korean hospital. J Antimicrob Chemother 2003, 51:619-623.